A proof-of-concept assay for quantitative and optical assessment of drug-induced toxicity in renal organoids

Abstract

Kidneys are complex organs, and reproducing their function and physiology in a laboratory setting remains difficult. During drug development, potential compounds may exhibit unexpected nephrotoxic effects, which imposes a significant financial burden on pharmaceutical companies. As a result, there is an ongoing need for more accurate model systems. The use of renal organoids to simulate responses to nephrotoxic insults has the potential to bridge the gap between preclinical drug efficacy studies in cell cultures and animal models, and the stages of clinical trials in humans. Here we established an accessible fluorescent whole-mount approach for nuclear and membrane staining to first provide an overview of the organoid histology. Furthermore, we investigated the potential of renal organoids to model responses to drug toxicity. For this purpose, organoids were treated with the chemotherapeutic agent doxorubicin for 48 h. When cell viability was assessed biochemically, the organoids demonstrated a significant, dose-dependent decline in response to the treatment. Confocal microscopy revealed visible tubular disintegration and a loss of cellular boundaries at high drug concentrations. This observation was further reinforced by a dose-dependent decrease of the nuclear area in the analyzed images. In contrast to other approaches, in this study, we provide a straightforward experimental framework for drug toxicity assessment in renal organoids that may be used in early research stages to assist screen for potential adverse effects of compounds.

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

“…Adverse drug reactions and toxic effects are significant challenges in drug development. iPSCs offer a reliable and scalable platform for assessing drug toxicity by differentiating them into organ-specific cell types [ 585 , 617 , 618 ]. By subjecting iPSC-derived cells to potential drug candidates, researchers can evaluate their safety profiles, identifying any potential toxic effects on specific organs or systems [ 620 ].…”